Medlab Clinical LTD sell "NanaBidial™"
Basic Information
380
14
5
3.9(34)
Subcategory & Sub-subcategory
Trade Type
Sell
Product Name
NanaBidial™
Details
Specifications
- Application: Sub-micron oro-buccal spray delivering an 18:1 CBD:THC ratio via the NanoCelle transmucosal delivery platform.
- Country of Origin: Developed by Medlab Clinical Ltd, an Australian investigational-product sponsor.
- Certification Standard: Evaluated in a completed exploratory pilot safety/tolerability/pharmacokinetic study registered at ANZCTR.
Other Information
Additional Description:
NanaBidial is an investigational sub-micron oro-buccal spray delivering roughly an 18:1 ratio of cannabidiol (CBD) to delta-9-THC (approximately 20 mg/mL CBD and under 1 mg/mL THC), built on the NanoCelle transmucosal delivery platform. It has been evaluated in a completed exploratory pilot study assessing the safety, tolerability, and pharmacokinetics of buccal CBD administration in healthy volunteers (ANZCTR ACTRN12617001491358), and is covered by an Australian transmucosal/transdermal delivery patent.
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment